Good day, 360!
The headlines are a real mixed bag this morning, but judging by stock futures, we may cruise into the weekend on a much-needed GREEN day. Here are some of our top movers 🔥. Be the best prepared trader on the Street!
FOCUS LIST🔎
MRM – Up over 30% in pre after announcing am executive makes additional investment in Mother Labs’ series A financing at a pre-money valuation of JPY9 Billion (as of March 13, 2025, approximately US$60 Million)
CLLS – Up over 17% in pre after announcing better than expected earnings
BZFD – Up over 19% in pre after reporting better than expected financial outlook
*sponsored by LookyLoo
Investors are jumping in – last chance to get on board.
LookyLOO is closing in on its final days.
With $1.2M in projected revenue, 4x growth in partnerships, and over 100K movers using the platform, the momentum behind this raise is real – and so is the deadline.
Don’t let this end without you. April 4th is the last day to invest.
Read the offering information carefully before investing. Obtain a Form C and offering Memorandum at https://wefunder.com/lookyloo
HOTLIST🔥
MRM – Up over 30% in pre after announcing am executive makes additional investment in Mother Labs’ series A financing at a pre-money valuation of JPY9 Billion (as of March 13, 2025, approximately US$60 Million)
MEDIROM Healthcare Technologies Inc. (MRM) together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty.
In the after-hours yesterday, the company announcedYasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., a subsidiary of the Company, has made a second investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion (as of March 13, 2025, approximately US$60 million). This new investment follows Mr. Hayami’s initial investment in the Series A financing in December 2024.
According to Finviz, based on yesterday’s close, MRM had a market capitalization of just $3.06 million.
Shares of MRM traded up over 30% in the pre-market in reaction to the news.
The $0.90 area acted as support in the pre-market and now becomes a potential level of resistance.
Above it, targets to the upside are $1.05, $1.24, $1.33 and then the after-hours high at $1.45. Beyond that, $1.50, $1.73 and $2.30 come into play.
Below $0.90, targets to the downside are $0.75, $0.70 and then a gap fill at $0.62.
CLLS – Up over 17% in pre after announcing better than expected earnings
Cellectis S.A. (CLLS) is a clinical stage biotechnological company that develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.
In the after-hours yesterday, the company provided financial results for the fourth quarter and full year 2024, ending December 31, 2024, and provided a business update.
Highlights include:
Cash position of $264 million as of December 31, 20241 provides runway into mid-2027.
UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD granted by the European Commission to UCART22 for the treatment of ALL.
UCART20x22 Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late 2025.
AstraZeneca partnership: R&D activities ongoing on three programs – one allogeneic CAR T for hematological malignancies, one allogeneic CAR T for solid tumors, and one in vivo gene therapy for a genetic disorder.
Shares of CLLS traded up over 17% in the pre-market in reaction to financial results and business update.
The $1.50 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $1.58, $1.80, $1.90 and then the pre-market high at $1.94. Beyond that, $2.10, $2.23 and $2.40 come into play.
Below $1.50, targets to the downside are $1.44 and then a gap fill at $1.29.
📈What Is the Propulsion Slide?📈
Jason’s #1 Indicator In Trump’s Market.
Stocks Are Discounted… Propulsion Trades ARE Coming.
BZFD – Up over 19% in pre after reporting better than expected financial outlook
BuzzFeed Inc. (BZFD) is a digital media company that distributes content across owned and operated, as well as third-party platforms.
In the after hours yesterday, the company reportedfourth quarter and full year (ended December 31, 2024) financial results and business update as well as 2025 financial outlook.
Highlights Include:
Full Year 2025 Financial Outlook
expect overall revenues in the range of $195 million to $210 million, or 3-10% higher than 2024.
expect Adjusted EBITDA in the range of $10 million to $20 million, an improvement of approximately $10 million year-over-year at the midpoint.
Shares of BZFD traded up over 19% in the pre-market in reaction to the news.
The first target for bulls is the pre-market high at $2.38. Beyond that, $2.50, $2.70, $3, $3.20 and $3.50 come into play.
Below $2.38, targets to the downside are $2.30, $2.20 and then a gap fill at $1.96.
MARKET NEWS 📰
Don’t miss out on our MOBILE ALERTS! Some of these alerts have rocketed 🚀past the MOON 🌝. Text “RAGE” to 1-(888) 487-1534📲.
*Disclosure: By texting “Alerts” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content:If you purchase anything through a link in this email other than RagingBull (RB) services, you should assume that we have an affiliate relationship with the company providing the product that you purchase, and that we will be paid in some way. RB is not responsible for any content hosted on affiliate’s sites and it is the affiliate’s responsibility to ensure compliance with applicable laws. We recommend that you do your own independent research before purchasing anything. While we believe in the companies we form affiliate relationships with, please don’t spend any money on these products unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
